# PRESENTATION: Opibiotix Health Plc at ProBiota, Berlin Feb 2017

- Link: https://www.directorstalkinterviews.com/presentation-opibiotix-health-plc-probiota-berlin-feb-2017/412723473
- Published: 2017-02-09T07:29:47+00:00
- Author: Giles Arbor

**OptiBiotix Health plc** (LON:OPTI), a life sciences business developing compounds
to tackle obesity, high cholesterol, diabetes and skin care, announced in January
that it has had two abstracts accepted for presentation at ProBiota 2017 in Berlin
from 1-3 February 2017. ProBiota is the leading annual event for the global prebiotic,
probiotic and the microbiota focused food and pharma industries. The conference 
is world renowned as a key meeting place for a community of scientists and business
leaders who want to translate science into new products in the growing supplements
and ingredients market.

CEO Stephen O’Hara talks through the presentation on LP-LDL®: Cholesterol & hypertension
reduction – Next generation pre, pro, and synbiotics that he gave at a conference
in Berlin on the 3rd Feb 2017 attended by over 250 scientists from around the world.

 

The two abstracts relate to the work that **OptiBiotix Health plc** has undertaken
on its cholesterol lowering probiotic. The first abstract will cover the results
of the clinical study and will be presented as a poster and oral presentation. The
second abstract will be presented as a poster and covers the work on species specific
microbiome modulators which the Company has used to enhance the cholesterol reducing
effect of their cholesterol reducing strain (LP-LDL®). In the case of this strain,
it leads to a threefold increase in the strains ability to lower cholesterol.

Share on:
